{"id":13837,"date":"2020-10-19T10:22:05","date_gmt":"2020-10-19T08:22:05","guid":{"rendered":"https:\/\/iph-multisite.berta-bewegt.ch\/?p=13837"},"modified":"2026-03-03T09:54:42","modified_gmt":"2026-03-03T08:54:42","slug":"interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes","status":"publish","type":"post","link":"https:\/\/www.interpharma.ch\/en\/blog\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\/","title":{"rendered":"Interview with Ren\u00e9 Buholzer: &#8220;The challenge for the future of innovation in Switzerland and for Swiss pharma companies in general is to once again adapt to technological changes&#8221;"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Interpharma CEO Dr Ren\u00e9 P Buholzer outlines the holistic strategy that needs to be put in place to maintain Switzerland\u2019s leading position in innovation, market access and reimbursement challenges for new medicines, and why an open, globalised Europe is key for security of supply. Read the interview below:<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Interpharma CEO Dr Ren\u00e9 P Buholzer outlines the holistic strategy that needs to be put in place to maintain Switzerland\u2019s leading position in innovation, market access and reimbursement challenges for new medicines, and why an open, globalised Europe is key for security of supply. Read the interview below:<\/p>\n","protected":false},"author":1,"featured_media":1529,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"tags":[68,152],"class_list":["post-13837","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tag-innovation","tag-pharmahub-switzerland"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.8 (Yoast SEO v28.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Interview with Ren\u00e9 Buholzer: the future of innovation<\/title>\n<meta name=\"description\" content=\"Interpharma CEO Ren\u00e9 Buholzer on the strategy needed to keep Switzerland\u2019s leading position in innovation and the challenges of market access.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.interpharma.ch\/en\/blog\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Interview with Ren\u00e9 Buholzer: &quot;The challenge for the future of innovation in Switzerland and for Swiss pharma companies in general is to once again adapt to technological changes&quot;\" \/>\n<meta property=\"og:description\" content=\"Interpharma CEO Ren\u00e9 Buholzer on the strategy needed to keep Switzerland\u2019s leading position in innovation and the challenges of market access.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.interpharma.ch\/en\/blog\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\/\" \/>\n<meta property=\"og:site_name\" content=\"Interpharma\" \/>\n<meta property=\"article:published_time\" content=\"2020-10-19T08:22:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-03T08:54:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2020\/02\/buholzer_portrait.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"853\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"berta_admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:site\" content=\"@interpharma_ch\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"berta_admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\\\/\"},\"author\":{\"name\":\"berta_admin\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/person\\\/1302f3da278bb3f8995756877d107818\"},\"headline\":\"Interview with Ren\u00e9 Buholzer: &#8220;The challenge for the future of innovation in Switzerland and for Swiss pharma companies in general is to once again adapt to technological changes&#8221;\",\"datePublished\":\"2020-10-19T08:22:05+00:00\",\"dateModified\":\"2026-03-03T08:54:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\\\/\"},\"wordCount\":77,\"publisher\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2020\\\/02\\\/buholzer_portrait.jpeg\",\"keywords\":[\"Innovation\",\"Pharmahub Switzerland\"],\"inLanguage\":\"en-US\",\"copyrightYear\":\"2020\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\\\/\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\\\/\",\"name\":\"Interview with Ren\u00e9 Buholzer: the future of innovation\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2020\\\/02\\\/buholzer_portrait.jpeg\",\"datePublished\":\"2020-10-19T08:22:05+00:00\",\"dateModified\":\"2026-03-03T08:54:42+00:00\",\"description\":\"Interpharma CEO Ren\u00e9 Buholzer on the strategy needed to keep Switzerland\u2019s leading position in innovation and the challenges of market access.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2020\\\/02\\\/buholzer_portrait.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2020\\\/02\\\/buholzer_portrait.jpeg\",\"width\":853,\"height\":853,\"caption\":\"Portr\u00e4t von Ren\u00e9 Buholzer, CEO Interpharma\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/blog\\\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.interpharma.ch\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Interview with Ren\u00e9 Buholzer: &#8220;The challenge for the future of innovation in Switzerland and for Swiss pharma companies in general is to once again adapt to technological changes&#8221;\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#website\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/\",\"name\":\"Interpharma\",\"description\":\"Verband der forschenden Pharmazeutischen Firmen\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.interpharma.ch\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#organization\",\"name\":\"Interpharma\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"contentUrl\":\"https:\\\/\\\/www.interpharma.ch\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg\",\"width\":\"1200\",\"height\":\"1200\",\"caption\":\"Interpharma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/interpharma_ch\",\"https:\\\/\\\/ch.linkedin.com\\\/company\\\/interpharma\",\"https:\\\/\\\/www.instagram.com\\\/interpharma_ch\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.interpharma.ch\\\/#\\\/schema\\\/person\\\/1302f3da278bb3f8995756877d107818\",\"name\":\"berta_admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g\",\"caption\":\"berta_admin\"},\"sameAs\":[\"https:\\\/\\\/www.interpharma.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Interview with Ren\u00e9 Buholzer: the future of innovation","description":"Interpharma CEO Ren\u00e9 Buholzer on the strategy needed to keep Switzerland\u2019s leading position in innovation and the challenges of market access.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.interpharma.ch\/en\/blog\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\/","og_locale":"en_US","og_type":"article","og_title":"Interview with Ren\u00e9 Buholzer: \"The challenge for the future of innovation in Switzerland and for Swiss pharma companies in general is to once again adapt to technological changes\"","og_description":"Interpharma CEO Ren\u00e9 Buholzer on the strategy needed to keep Switzerland\u2019s leading position in innovation and the challenges of market access.","og_url":"https:\/\/www.interpharma.ch\/en\/blog\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\/","og_site_name":"Interpharma","article_published_time":"2020-10-19T08:22:05+00:00","article_modified_time":"2026-03-03T08:54:42+00:00","og_image":[{"width":853,"height":853,"url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2020\/02\/buholzer_portrait.jpeg","type":"image\/jpeg"}],"author":"berta_admin","twitter_card":"summary_large_image","twitter_creator":"@interpharma_ch","twitter_site":"@interpharma_ch","twitter_misc":{"Written by":"berta_admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.interpharma.ch\/en\/blog\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\/#article","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\/"},"author":{"name":"berta_admin","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818"},"headline":"Interview with Ren\u00e9 Buholzer: &#8220;The challenge for the future of innovation in Switzerland and for Swiss pharma companies in general is to once again adapt to technological changes&#8221;","datePublished":"2020-10-19T08:22:05+00:00","dateModified":"2026-03-03T08:54:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\/"},"wordCount":77,"publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"image":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2020\/02\/buholzer_portrait.jpeg","keywords":["Innovation","Pharmahub Switzerland"],"inLanguage":"en-US","copyrightYear":"2020","copyrightHolder":{"@id":"https:\/\/www.interpharma.ch\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.interpharma.ch\/en\/blog\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\/","url":"https:\/\/www.interpharma.ch\/en\/blog\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\/","name":"Interview with Ren\u00e9 Buholzer: the future of innovation","isPartOf":{"@id":"https:\/\/www.interpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\/#primaryimage"},"image":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\/#primaryimage"},"thumbnailUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2020\/02\/buholzer_portrait.jpeg","datePublished":"2020-10-19T08:22:05+00:00","dateModified":"2026-03-03T08:54:42+00:00","description":"Interpharma CEO Ren\u00e9 Buholzer on the strategy needed to keep Switzerland\u2019s leading position in innovation and the challenges of market access.","breadcrumb":{"@id":"https:\/\/www.interpharma.ch\/en\/blog\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.interpharma.ch\/en\/blog\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.interpharma.ch\/en\/blog\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\/#primaryimage","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2020\/02\/buholzer_portrait.jpeg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2020\/02\/buholzer_portrait.jpeg","width":853,"height":853,"caption":"Portr\u00e4t von Ren\u00e9 Buholzer, CEO Interpharma"},{"@type":"BreadcrumbList","@id":"https:\/\/www.interpharma.ch\/en\/blog\/interview-with-rene-buholzer-the-challenge-for-the-future-of-innovation-in-switzerland-and-for-swiss-pharma-companies-in-general-is-to-once-again-adapt-to-technological-changes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.interpharma.ch\/en\/"},{"@type":"ListItem","position":2,"name":"Interview with Ren\u00e9 Buholzer: &#8220;The challenge for the future of innovation in Switzerland and for Swiss pharma companies in general is to once again adapt to technological changes&#8221;"}]},{"@type":"WebSite","@id":"https:\/\/www.interpharma.ch\/#website","url":"https:\/\/www.interpharma.ch\/","name":"Interpharma","description":"Verband der forschenden Pharmazeutischen Firmen","publisher":{"@id":"https:\/\/www.interpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.interpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.interpharma.ch\/#organization","name":"Interpharma","url":"https:\/\/www.interpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","contentUrl":"https:\/\/www.interpharma.ch\/wp-content\/uploads\/2026\/03\/20251014_iph_logo_wort_bildmarke_rgb_final_cu01.svg","width":"1200","height":"1200","caption":"Interpharma"},"image":{"@id":"https:\/\/www.interpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/interpharma_ch","https:\/\/ch.linkedin.com\/company\/interpharma","https:\/\/www.instagram.com\/interpharma_ch\/"]},{"@type":"Person","@id":"https:\/\/www.interpharma.ch\/#\/schema\/person\/1302f3da278bb3f8995756877d107818","name":"berta_admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a2aeb00900e30743ff2859dfc3dd11cf7e64bb4ec7a1f349ee3772658a1d087d?s=96&d=mm&r=g","caption":"berta_admin"},"sameAs":["https:\/\/www.interpharma.ch"]}]}},"_links":{"self":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts\/13837","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/comments?post=13837"}],"version-history":[{"count":1,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts\/13837\/revisions"}],"predecessor-version":[{"id":13838,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/posts\/13837\/revisions\/13838"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/media\/1529"}],"wp:attachment":[{"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/media?parent=13837"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.interpharma.ch\/en\/wp-json\/wp\/v2\/tags?post=13837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}